Display Settings:

Format

Send to:

Choose Destination
    J Antibiot (Tokyo). 1992 Nov;45(11):1746-52.

    Epoxomicin, a new antitumor agent of microbial origin.

    Source

    Bristol-Myers Squibb Research Institute, Tokyo, Japan.

    Abstract

    An actinomycete strain No. Q996-17 produced a novel compound, epoxomicin, which exhibited in vivo antitumor activity against B16 melanoma. Structural studies indicated that it is a new member of the epoxy-beta-aminoketone group, and is closely related to eponemycin.

    PMID:
    1468981
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk